These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15109204)

  • 1. Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia.
    Fodale V; Praticò C; Santamaria LB
    Eur J Anaesthesiol; 2004 Apr; 21(4):333-4; author reply 334-5. PubMed ID: 15109204
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rocuronium-cisatracurium combinations.
    Donati F; Plaud B
    Anesthesiology; 1999 Aug; 91(2):587-8. PubMed ID: 10443637
    [No Abstract]   [Full Text] [Related]  

  • 4. Rocuronium and cisatracurium.
    Pollard BJ
    Br J Hosp Med; 1997 Apr 2-15; 57(7):346-8. PubMed ID: 9217862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cerebral and cardiovascular effects of cisatracurium and atracurium in neurosurgical patients.
    Schramm WM; Papousek A; Michalek-Sauberer A; Czech T; Illievich U
    Anesth Analg; 1998 Jan; 86(1):123-7. PubMed ID: 9428865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamics of mivacurium preceded by atracurium or cisatracurium in children.
    Jalkanen L; Rautoma P; Taivainen T; Meretoja OA
    Anesth Analg; 1998 Jan; 86(1):62-5. PubMed ID: 9428852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis.
    Kirov K; Motamed C; Decailliot F; Behforouz N; Duvaldestin P
    Acta Anaesthesiol Scand; 2004 May; 48(5):577-81. PubMed ID: 15101851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of atracurium and cisatracurium and the use of diphenhydramine and cimetidine.
    Correa CM; Sudo GZ; Sudo RT
    Rev Bras Anestesiol; 2010; 60(1):52-63. PubMed ID: 20169263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB; Walker SC; Fontenot JP
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia.
    Wulf H; Kahl M; Ledowski T
    Br J Anaesth; 1998 Mar; 80(3):308-12. PubMed ID: 9623429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cisatricurium in the orbicularis oculi muscle. Comparisn of the neuromuscular action of cisatracurium and atracurium in the orbicularis oculi muscle and the adductor pollicis muscle].
    de Rossi L; Fritz H; Kröber L; Klein U
    Anaesthesist; 1999 Sep; 48(9):602-6. PubMed ID: 10525592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients.
    Keleş GT; Yentür A; Cavuş Z; Sakarya M
    Eur J Anaesthesiol; 2004 Nov; 21(11):877-81. PubMed ID: 15717704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 15. Benzylisochinoline muscle relaxants in clinical practice.
    Werba A; Schultz AM; Hetz H; Wiesinger KH
    Acta Anaesthesiol Scand Suppl; 1997; 111():109-10. PubMed ID: 9420976
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease.
    Reich DL; Mulier J; Viby-Mogensen J; Konstadt SN; van Aken HK; Jensen FS; DePerio M; Buckley SG
    Can J Anaesth; 1998 Aug; 45(8):794-7. PubMed ID: 9793671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible neuroprotective effect of laudanosine, an atracurium and cisatracurium metabolite.
    Fodale V; Santamaria LB
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):780; 780-1. PubMed ID: 12803601
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with rocuronium to accelerate the onset time of cisatracurium during intubation.
    Lin SP; Chang KY; Chen YJ; Lin SM; Chang WK; Chan KH; Ting CK
    J Chin Med Assoc; 2009 Jan; 72(1):15-9. PubMed ID: 19181592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
    Searle NR; Thomson I; Dupont C; Cannon JE; Roy M; Rosenbloom M; Gagnon L; Carrier M
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.